We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+28.35%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.48B
AUM Growth
-$34.8M
Cap. Flow
-$328M
Cap. Flow %
-22.14%
Top 10 Hldgs %
6.75%
Holding
913
New
211
Increased
150
Reduced
301
Closed
241

Top Buys

Rank Stock Value
1
SMG icon
ScottsMiracle-Gro
SMG
+$5.68M
2
ACGL icon
Arch Capital
ACGL
+$5.65M
3
DDOG icon
Datadog
DDOG
+$5.54M
4
OLLI icon
Ollie's Bargain Outlet
OLLI
+$5.38M
5
NEE icon
NextEra Energy
NEE
+$5.27M

Sector Composition

Rank Sector Weight
1 Healthcare 22.47%
2 Technology 21.77%
3 Consumer Discretionary 18.47%
4 Industrials 10.54%
5 Financials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AWR icon
226
American States Water
AWR
$3.44B
$2.51M 0.17%
31,515
-3,789
-11% -$290K
BWXT icon
227
BWX Technologies
BWXT
$14.4B
$2.47M 0.17%
40,964
-40,736
-50% -$2.35M
CHRS icon
228
Coherus Oncology
CHRS
$217M
$2.39M 0.16%
137,400
-190
-0.1% -$3.38K
CLB icon
229
Core Laboratories
CLB
$455M
$2.39M 0.16%
90,091
-35,307
-28% -$721K
PRMW
230
DELISTED
Primo Water Corporation
PRMW
$2.36M 0.16%
150,768
-22,611
-13% -$333K
HLNE icon
231
Hamilton Lane
HLNE
$3.88B
$2.36M 0.16%
+30,201
New +$2.19M
AQUA
232
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$2.33M 0.16%
86,532
+5,531
+7% +$137K
ATRA icon
233
Atara Biotherapeutics
ATRA
$72.6M
$2.33M 0.16%
4,738
-378
-7% -$174K
LL
234
DELISTED
LL Flooring Holdings, Inc.
LL
$2.32M 0.16%
75,348
-63,616
-46% -$1.77M
VCEL icon
235
Vericel Corp
VCEL
$2.38B
$2.25M 0.15%
73,035
-9,272
-11% -$221K
WD icon
236
Walker & Dunlop
WD
$1.73B
$2.25M 0.15%
24,437
-10,616
-30% -$787K
ZUO
237
DELISTED
Zuora, Inc.
ZUO
$2.25M 0.15%
161,316
+9,015
+6% +$102K
FFIN icon
238
First Financial Bankshares
FFIN
$5.05B
$2.21M 0.15%
61,000
-28,489
-32% -$934K
CSOD
239
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$2.21M 0.15%
50,104
-24,806
-33% -$1.03M
TDOC icon
240
Teladoc Health
TDOC
$1.66B
$2.2M 0.15%
11,006
-15,894
-59% -$3.23M
CWEN icon
241
Clearway Energy Class C
CWEN
$4.79B
$2.18M 0.15%
68,388
-6,166
-8% -$185K
ALEC icon
242
Alector
ALEC
$169M
$2.14M 0.14%
141,425
-33,173
-19% -$412K
IMGN
243
DELISTED
Immunogen Inc
IMGN
$2.13M 0.14%
330,700
-17,600
-5% -$103K
YEXT icon
244
Yext
YEXT
$573M
$2.13M 0.14%
135,442
+33,498
+33% +$573K
AVAV icon
245
AeroVironment
AVAV
$7.19B
$2.07M 0.14%
23,800
-8,409
-26% -$675K
CORE
246
DELISTED
Core Mark Holding Co., Inc.
CORE
$2.06M 0.14%
70,222
-11,082
-14% -$339K
RGNX icon
247
Regenxbio
RGNX
$616M
$2.04M 0.14%
44,990
-18,333
-29% -$641K
PRFT
248
DELISTED
Perficient Inc
PRFT
$1.98M 0.13%
41,639
-6,364
-13% -$289K
BCPC
249
Balchem Corp
BCPC
$5.26B
$1.96M 0.13%
17,000
-8,803
-34% -$929K
AMRC icon
250
Ameresco
AMRC
$980M
$1.94M 0.13%
37,071
+11,371
+44% +$490K

Similar funds

PDT Partners's Q4 2020 Portfolio in Review

As of Q4 2020, PDT Partners held 913 positions worth $1.48B, down 2.3% from $1.51B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.

PDT Partners withdrew a net $328M in Q4 2020, closing 241 positions and reducing 301 holdings. Its most notable exit was Lam Research, an estimated $8.46M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, PDT Partners opened a new position in ScottsMiracle-Gro worth $6.59M.

  • PDT Partners's largest Q4 2020 buy was ScottsMiracle-Gro: 33,110 shares worth $6.59M.
  • PDT Partners added most to Arch Capital in Q4 2020, an estimated $5.65M increase.
  • PDT Partners's biggest Q4 2020 reduction was Ferrari, cutting an estimated $12.2M.
  • PDT Partners fully exited Lam Research in Q4 2020, selling an estimated $8.46M.
  • PDT Partners's ten largest holdings make up 6.7% of its $1.48B portfolio in Q4 2020.
  • PDT Partners opened 211 new positions and closed 241 in Q4 2020.
  • PDT Partners's portfolio value fell 2.3% quarter-over-quarter to $1.48B.

Based on PDT Partners's 13F filing for Q4 2020, filed 16 Feb 2021.